Lupin launches generic prostatic hyperplasia treatment drug in US

Lupin launches generic prostatic hyperplasia treatment drug in US The company has launched its Silodosin capsules in the strengths of 4 mg and 8 mg after receiving an approval from USFDA.

No comments:

Post a Comment